Company Background
Galen Limited is a privately owned pharmaceutical sales and marketing company established in 1968. Based in Craigavon (Northern Ireland) Galen promotes branded and generic prescription medicines in the United Kingdom and Ireland, with major brands in key therapeutic areas, particularly COPD, women's health, urology and pain management. By combining innovation in product development with competitive pricing, Galen aims to work in partnership with healthcare professionals and patients, a major factor in the company's success to date.
Galen's future strategy is aimed at the commercialisation of innovative proprietary products on a global basis, in addition to an ongoing expansion of the product pipeline through in-licensing and acquisition opportunities.
In April 2004 the company was acquired by Sir Allen McClay, the original founder of Galen and the owner of a group of pharmaceutical services companies under the umbrella of the Almac Group. The Almac Group has access to a wide variety of services, which ranges from drug discovery through to clinical trials' management and commercial manufacture.
Galen is now well placed to fulfil our vision of creating an international pharmaceutical company from its base in Northern Ireland. Key to achieving this vision will be developing our core values of innovation, quality, people and customer focus.